Global microRNA profiling using novel LNA enhanced microarrays enables identification of tumors of unknown primary origin

被引：0
|
作者：
Sokilde, R. [1 ]
Hoiby, P. E. [1 ]
Friis, G. [1 ]
Hansen, A. [2 ]
Moller, S. [1 ]
Litman, T. [1 ]
机构：
[1] Exiqon A S, DK-2950 Vedbaek, Denmark
[2] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark
来源：
APMIS | 2008年 / 116卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：430 / 430
页数：1
相关论文
共 30 条
  • [1] MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin
    Ferracin, Manuela
    Pedriali, Massimo
    Veronese, Angelo
    Zagatti, Barbara
    Gafa, Roberta
    Magri, Eros
    Lunardi, Maria
    Munerato, Gardenia
    Querzoli, Giulia
    Maestri, Iva
    Ulazzi, Linda
    Nenci, Italo
    Croce, Carlo M.
    Lanza, Giovanni
    Querzoli, Patrizia
    Negrini, Massimo
    JOURNAL OF PATHOLOGY, 2011, 225 (01): : 43 - 53
  • [2] Global miRNA and pre-miRNA expression profiling of the NCI-60 cancer cell lines using novel LNA enhanced microarrays
    Kaczkowski, B.
    Sokilde, R.
    Stahlberg, N.
    Gorodkin, J.
    Litman, T.
    APMIS, 2008, 116 (05) : 429 - 429
  • [3] Efficient identification of tumor of unknown primary origin by its microRNA profile
    Sokilde, Rolf
    Moller, Anne K.
    Vincent, Martin
    Nielsen, Boye S.
    Hansen, Alastair
    Daugaard, Gedske
    Moller, Soren
    Litman, Thomas
    CANCER RESEARCH, 2010, 70
  • [4] Accurate identification of primary site in tumors of unknown origin (TUO) using DNA methylation
    Duckett, Drew
    Vormittag-Nocito, Erica R.
    Jamshidi, Pouya
    Sukhanova, Madina
    Parker, Stephanie
    Brat, Daniel J.
    Jennings, Lawrence J.
    Santana-Santos, Lucas
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [5] Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin
    Saller, James J.
    Haider, Mintallah
    Al-Diffalha, Sameer
    Coppola, Domenico
    ANTICANCER RESEARCH, 2022, 42 (03) : 1381 - 1396
  • [6] Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors
    George Pentheroudakis
    Yael Spector
    Dimitrios Krikelis
    Vassiliki Kotoula
    Eti Meiri
    Vassiliki Malamou-Mitsi
    George Fountzilas
    Mats Sanden
    Nicholas Pavlidis
    Hila Benjamin
    Ranit Aharonov
    Clinical & Experimental Metastasis, 2013, 30 : 431 - 439
  • [7] Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors
    Pentheroudakis, George
    Spector, Yael
    Krikelis, Dimitrios
    Kotoula, Vassiliki
    Meiri, Eti
    Malamou-Mitsi, Vassiliki
    Fountzilas, George
    Sanden, Mats
    Pavlidis, Nicholas
    Benjamin, Hila
    Aharonov, Ranit
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (04) : 431 - 439
  • [8] MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
    Laprovitera, Noemi
    Riefolo, Mattia
    Porcellini, Elisa
    Durante, Giorgio
    Garajova, Ingrid
    Vasuri, Francesco
    Aigelsreiter, Ariane
    Dandachi, Nadia
    Benvenuto, Giuseppe
    Agostinis, Federico
    Sabbioni, Silvia
    Berindan Neagoe, Ioana
    Romualdi, Chiara
    Ardizzoni, Andrea
    Trere, Davide
    Pichler, Martin
    D'Errico, Antonietta
    Ferracin, Manuela
    MOLECULAR ONCOLOGY, 2021, 15 (10) : 2732 - 2751
  • [9] Insights into the epithelial mesenchymal transition phenotype in cancer of unknown primary from a global microRNA profiling study
    A. Stoyianni
    G. Pentheroudakis
    H. Benjamin
    A. Cervantes
    K. Ashkenazi
    G. Lazaridis
    N. Pavlidis
    Y. Spector
    Clinical and Translational Oncology, 2014, 16 : 725 - 731
  • [10] Insights into the epithelial mesenchymal transition phenotype in cancer of unknown primary from a global microRNA profiling study
    Stoyianni, A.
    Pentheroudakis, G.
    Benjamin, H.
    Cervantes, A.
    Ashkenazi, K.
    Lazaridis, G.
    Pavlidis, N.
    Spector, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (08): : 725 - 731
123